Given the profound impact of BMI on leptin levels and the prominent role of obesity in endometrial cancer, leptin may not be an ideal candidate as a diagnostic or prognostic marker for this cancer. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.